InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Schiff Andrew N, 董事. Insider active across 1 company, notably Aclaris Therapeutics, Inc.. In total, 10 filings have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €1.3m. History available since 17 June 2022. The latest transaction was disclosed on 10 November 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Andrew N. Schiff is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing treatments for dermatological diseases. As a board member, he participates in overseeing the company's strategies and making key decisions. Andrew brings expertise in biotechnology and drug development.